PL3606505T3 - Kompozycja do podawania donosowego - Google Patents

Kompozycja do podawania donosowego

Info

Publication number
PL3606505T3
PL3606505T3 PL18721711T PL18721711T PL3606505T3 PL 3606505 T3 PL3606505 T3 PL 3606505T3 PL 18721711 T PL18721711 T PL 18721711T PL 18721711 T PL18721711 T PL 18721711T PL 3606505 T3 PL3606505 T3 PL 3606505T3
Authority
PL
Poland
Prior art keywords
composition
nasal application
nasal
application
Prior art date
Application number
PL18721711T
Other languages
English (en)
Inventor
Markus UNKAUF
Holger Miething
Original Assignee
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh filed Critical Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh
Publication of PL3606505T3 publication Critical patent/PL3606505T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL18721711T 2017-07-31 2018-04-20 Kompozycja do podawania donosowego PL3606505T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102017007144 2017-07-31
DE102017007171 2017-08-01
DE102017117987.9A DE102017117987A1 (de) 2017-07-31 2017-08-08 Neue Zusammensetzung für die nasale Applikation
EP18721711.2A EP3606505B1 (de) 2017-07-31 2018-04-20 Zusammensetzung für die nasale applikation
PCT/EP2018/060132 WO2019025040A1 (de) 2017-07-31 2018-04-20 Zusammensetzung für die nasale applikation

Publications (1)

Publication Number Publication Date
PL3606505T3 true PL3606505T3 (pl) 2021-06-28

Family

ID=63171337

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18721711T PL3606505T3 (pl) 2017-07-31 2018-04-20 Kompozycja do podawania donosowego

Country Status (5)

Country Link
EP (1) EP3606505B1 (pl)
DE (2) DE102017117987A1 (pl)
ES (1) ES2860098T3 (pl)
PL (1) PL3606505T3 (pl)
WO (1) WO2019025040A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019125330A2 (en) * 2017-08-10 2019-06-27 Eli̇xi̇r İlaç Araştirma Ve Geli̇şti̇rme A.Ş. Nasal decongestant compositions comprising dexpanthenol and sodium hyaluronate
WO2022170405A1 (pt) * 2021-02-12 2022-08-18 Master Indústria E Comércio De Produtos Odontológicos E Farmacêuticos Ltda Me Composição farmacêutica de hialuronato de sódio aquosa em forma de spray nasal
WO2023046590A1 (en) 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof
WO2023144614A1 (en) * 2022-01-28 2023-08-03 Avaca Pharma Private Limited Nasal compositions and methods thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549421C2 (de) 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19541919C2 (de) 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE10161110A1 (de) * 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
DE10337186A1 (de) 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
DE10356248A1 (de) 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
DE102011010668A1 (de) * 2011-02-08 2012-08-09 Ursapharm Arzneimittel Gmbh Wässrige pharmazeutische Zusammensetzung zur Prävention und/oder Therapie allergisch gereizter Nasenschleimhaut und dessen Verwendung
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
DE102012005452A1 (de) * 2011-12-30 2013-07-04 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
DE202012005650U1 (de) * 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis

Also Published As

Publication number Publication date
EP3606505A1 (de) 2020-02-12
EP3606505B1 (de) 2021-01-06
DE102017117987A1 (de) 2019-01-31
DE202017104738U1 (de) 2018-08-01
ES2860098T3 (es) 2021-10-04
WO2019025040A1 (de) 2019-02-07

Similar Documents

Publication Publication Date Title
ZA202002723B (en) Composition
IL265360A (en) Pharmaceutical composition
GB2562466B (en) Composition
GB201703455D0 (en) Composition
GB201707238D0 (en) Composition
PL3331498T3 (pl) Kompozycja donosowa
GB201719139D0 (en) Composition
GB201700504D0 (en) Composition
GB201713636D0 (en) Composition
PL3675653T3 (pl) Kompozycja przeciwmykotoksynowa
GB201702833D0 (en) Composition
GB201521774D0 (en) Coating composition
GB201712151D0 (en) Composition
PT3576546T (pt) Composição probiótica
GB201721674D0 (en) Composition
GB201718871D0 (en) Composition
GB201711446D0 (en) Composition
GB201709905D0 (en) Composition
GB201707920D0 (en) Composition
ZA201904385B (en) Composition
GB201816988D0 (en) Composition
GB201715135D0 (en) Composition
PL3297603T3 (pl) Wodna kompozycja zawierająca cyneol do podawania donosowego
GB201703457D0 (en) Composition
DK3211049T3 (en) Coating composition